Washington (AP)-Robert F. Kennedy Jr. has won the political support that was necessary to become the country’s highest health officer by committed to the approval and apply of vaccines within the decades. However, his supervisory authorities promise major changes that cloud the prospects for the possibly available recordings.
According to Commissioner Marty Makary, the Food and Drug Administration will soon “release a massive framework for the tested and approved vaccines”. Details are not yet public, but the plan will be made by the modern agency’s modern boss of vaccines, Dr. Vinay Prasad, a pronounced critic of the FDA treatment of COVID-19-BOOSTERS.
Makary and other civil servants from the Trump management have already taken unprecedented steps to augment uncertainty about the COVID 19 vaccinations of the next autumn, including the delay in the approval of Novavax ‘Functional and then to restrict their apply for people with a higher risk from the virus. They have also suggested that seasonal improvements to the latest circulating viruses correspond to modern products that require additional tests.
The changes exceed several health authorities.
The centers for the control and prevention of diseases have not yet caused the latest recommendations for modern meningitis or a broader RSV vaccination to the latest recommendations for modern meningitis or a broader RSV vaccination. A meeting of Kennedy’s “Make America Healthy Again” allies has recently been announced that it should expect an end to the Covid 19-booster recommendations for children-otwas that should be discussed in June. And researchers across the country lost the national financing of the healthcare system to examine vaccines.
“I think you have to assume that RFK Jr. Amesh Adalja, a vaccine expert at John’s Hopkins University. The changes are “suspected, since this is someone with a proven track record to escape the value of vaccines.”
Increase doubts about vaccines
In a hearing from the Senate Health Committee last week, Kennedy mistakenly claimed that the only vaccines that were tested against a placebo or dummy shot were for Covid-19.
Senator Bill Cassidy, a Republican in Louisiana, who chairs the committee, briefly interrupted the hearing to say: “For the recording, that’s not true”-and indicates on placebo-controlled studies by the rotavirus, measles and HPV vaccines.
With regard to the rhetoric about how vaccines are tested, a group of doctors recently put together a list of more than 120 clinical vaccination studies that included decades.
“It directly exposes the claim that vaccines have never been tested against placebo,” said Dr. Jake Scott, a doctor for Stanford University’s infectious diseases, who heads the project.
Antivaccine groups argue that some substances that scientists call a placebo may not really be qualified, although the list occurs frequently.
Sometimes a vaccine causes enough pain or swelling that it is obvious who gets the vaccine and who in the is in the control group-and studies could apply a different option that can easily stimulate the skin to keep the test “blinded”, Scott said.
And if there is already a proven vaccine for the same disease, it is unethical to test a modern version against a placebo, he said.
“We cannot always expect to attempts from placebo -controlled,” said Scott. “It is essential that it is clearly communicated to the public, but it is a challenge, especially if there is so much noise and so much misinformation on social media.”
Trump officer stopped the decision of the vaccine
The promise of the administration to promise a modern vaccine framework takes place before a meeting on Thursday, at which FDA consultants will discuss the update of COVID-19 shots for this autumn and winter.
The credibility of the FDA has long been based on the independence of its scientific decisions. While the agency is managed by a handful of political representative, the approval decisions are almost always treated by career scholars.
But this standard seems to be postponed. The FDA employees were ready to approve the Novavax vaccine at the beginning of the last month, but the decision was delayed by administrative officials, including Makary,, according to two people with direct knowledge of the situation, which spoke about the condition of anonymity to discuss agency matters. The shot was approved tardy Friday with unusual restrictions.
Dr. Tracy Beth Hoeg, a political representative who acted as a special assistant of Makary, was involved in the unprecedented claim that Novavax carried out a modern clinical study on the shot after the approval. The requirement came shortly after the agency’s long -time vaccine leader, Dr. Peter Marks, was forced to step down.
Hoeg together with Makary and Prasad-brought a vast part of the Covid 19 pandemic to criticize the handling of FDA booster shots, especially in children and teenage adults. All three were co-authors of a 2022-paper, which shows that the requirement of booster shots in teenage people would cause more damage than benefits.
Novavax is not the only vaccine manufacturer that is already affected by changed settings at the FDA. At the beginning of this month, Moderna returned the target date for the modern COVID and flu combination vaccine to the next year after the FDA requested additional effective data.
COVID-19-BOOSTER critics have control
As the official official Vaccines of the FDA, Prasad is now able to reverse what he recently referred to as the “number of flour kicks” in the way the FDA evaluated the advantages and risks of COVID-19-BOOSTER.
He questioned how much benefits the annual vaccinations continue to offer. In a podcast shortly before he accepted his FDA job, Prasad suggested that companies could study around 20,000 older adults in August or September to prove whether an updated vaccine prevents covid-related hospital stays.
There is “a legitimate debate about who should be reinforced, how often they should be increased and how the value of people strengthens with little risk,” said Hopkins’ Adalja. However, he emphasized that the advisory committee for CDC vaccination practices has the right specialist knowledge in order to make these decisions.
And other experts say that you simply update the trunk that a Covid 19 vaccine goal does not show power and data in the real world that offers advantages every autumn update.
“The data is clear and convincing” that vaccination reduces the risk of senior citizens for hospital stays and grave illnesses for four to six months, said Michael Osterholm, researcher of the University of Minnesota.
This type of study could not be carried out quickly enough to have millions of people vaccinated before the annual winter switch, said Dr. Jesse Goodman from Georgetown University, former FDA vaccine leader.
“You would always carry out clinical studies and never have a vaccine that was up to date,” he said.
___
The Department of Health and Science from Associated Press receives support from the Science and Educational Media Group of the Howard Hughes Medical Institute and Robert Wood Johnson Foundation. The AP is only responsible for all content.
